Health Catalyst, Inc. (HCAT)
- Previous Close
8.23 - Open
8.36 - Bid 8.38 x 200
- Ask 8.41 x 200
- Day's Range
8.11 - 8.42 - 52 Week Range
5.42 - 11.41 - Volume
711,575 - Avg. Volume
564,652 - Market Cap (intraday)
507.345M - Beta (5Y Monthly) 1.32
- PE Ratio (TTM)
-- - EPS (TTM)
-1.49 - Earnings Date Oct 31, 2024 - Nov 4, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
10.85
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
www.healthcatalyst.com1,300
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HCAT
View MorePerformance Overview: HCAT
Trailing total returns as of 9/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HCAT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HCAT
View MoreValuation Measures
Market Cap
507.35M
Enterprise Value
447.76M
Trailing P/E
--
Forward P/E
21.79
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.63
Price/Book (mrq)
1.42
Enterprise Value/Revenue
1.50
Enterprise Value/EBITDA
-4.96
Financial Highlights
Profitability and Income Statement
Profit Margin
-28.87%
Return on Assets (ttm)
-6.58%
Return on Equity (ttm)
-23.15%
Revenue (ttm)
299.48M
Net Income Avi to Common (ttm)
-86.45M
Diluted EPS (ttm)
-1.49
Balance Sheet and Cash Flow
Total Cash (mrq)
308.26M
Total Debt/Equity (mrq)
69.66%
Levered Free Cash Flow (ttm)
27.76M